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ABSTRACT
Short regulatory RNAs are widespread in bacteria,
and many function through antisense recognition
of mRNA. Among the best studied antisense
transcripts are RNA antitoxins that repress toxin
mRNA translation. The hok/sok locus of plasmid R1
from Escherichia coli is an established model for
RNA antitoxin action. Base-pairing between hok
mRNA and Sok-antisense-RNA increases plasmid
maintenance through post-segregational-killing of
plasmid-free progeny cells. To test the model and
the idea that sequestration of Sok-RNA activity could
provide a novel antimicrobial strategy, we designed
anti Sok peptide nucleic acid (PNA) oligomers that,
according to the model, would act as competitive
inhibitors of hok mRNA::Sok-RNA interactions. In
hok/sok-carrying cells, anti Sok PNAs were more
bactericidal than rifampicin. Also, anti Sok PNAs
induced ghost cell morphology and an accumulation
of mature hok mRNA, consistent with cell killing
through synthesis of Hok protein. The results sup-
port the sense/antisense model for hok mRNA
repression by Sok-RNA and demonstrate that anti-
sense agents can be used to out-compete RNA::RNA
interactions in bacteria. Finally, BLAST analyses of
200 prokaryotic genomes revealed that many
enteric bacteria have multiple hok/sok homologous
and analogous RNA-regulated toxin–antitoxin loci.
Therefore, it is possible to activate suicide in bacteria
by targeting antitoxins.
INTRODUCTION
Non-coding regulatory RNAs are widely expressed in many
genomes (1,2). A large number of non-coding RNAs are
complementary to active open reading frames, yet there is
only limited evidence for direct sense/antisense interactions.
Antisense transcripts are encoded both in-cis and in-trans
and are believed to modulate RNA processing, decay and
translation through direct pairing with complementary target
sequences (3). Bacterial genomes and plasmids contain a
number of annotated as well as predicted sense and antisense
genes. Despite predictions of widespread sense/antisense
pairing in several species (4–7), there have been few attempts
to experimentally probe these structures and test the effects of
disrupted interactions (8).
A paradigm for sense/antisense RNA pairing is the hok/sok
toxin–antitoxin (TA) plasmid stabilization locus of the
R1 plasmid in E. coli (9). The hok/sok locus codes for three
genes: hok (host killing) encodes a highly toxic trans-
membrane protein that irreversibly damages the cell mem-
brane (10). The mok (modulation of killing) reading frame
overlaps with hok sequences and is required for hok expres-
sion and translation. Finally, the sok (suppression of killing)
gene encodes a small antisense RNA in-cis that blocks trans-
lation of the mok reading frame and thus inhibits expression
of hok mRNA (11). Pairing between Sok and hok transcripts
is supported by in vitro and phylogenetic studies (12–14).
Sok-RNA is very unstable (half-life in the order of 30 s)
but driven by a strong promoter. In contrast, the full-length
hok transcript is heavily structured, stable (half-life in the
order of 30 min) and inaccessible to either ribosome initiation
or Sok-RNA binding. Slow 30 end processing of hok mRNA
results in mature transcripts that are accessible for translation
and Sok-RNA binding. In the presence of a hok/sok-carrying
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plasmid, Sok-RNA binds to the mature form of hok mRNA
and represses translation by preventing ribosome entry
(15–17). In addition, formation of the hok mRNA::Sok-
RNA duplex leads to rapid RNase III-mediated degradation
(scavenging) of the mature and translatable form of hok
mRNA (18). In cases where the plasmid is lost, the
Sok-RNA pool is depleted through rapid decay and this
frees hok mRNA for translation and toxin production
kills the cell (19). Hok toxin causes dramatic changes in
cell morphology, resulting in characteristic ‘ghost cells’,
where the cell poles appear dense relative to the cell
centre (9,10). Therefore, the hok/sok system provides
plasmid stability through post-segregational killing of
plasmid free progeny. This mechanism of controlled expres-
sion of Hok toxin confers increased plasmid maintenance,
and this may provide a net benefit to cells by maintain-
ing plasmid encoded virulence or stress resistance traits.
A simplified model of the hok/sok system is shown in
Figure 1. Additional details of the hok/sok system
and other TA systems were reviewed by Gerdes and co-
workers (20).
We aimed to test the sense/antisense pairing model for hok
mRNA::Sok-RNA interactions in cells and also test possibili-
ties to induce Hok-mediated killing using an antisense agent.
Short synthetic peptide nucleic acid (PNA) oligomers
complementary to Sok sequences were designed to act as
competitive inhibitors of sense/antisense interactions. Anti
Sok PNAs added to growing cells caused growth arrest and
were bactericidal. Also, PNA-treated cells showed the
‘ghost’ cell morphology and RNA maturation changes
characteristic of Hok toxin-mediated cell killing. Finally,
using database searches, we revealed a large number of
hok/sok and another family of antisense RNA-regulated
toxin genes, ldr, in enteric bacterial genomes.
MATERIALS AND METHODS
Bacteria, plasmids and PNAs
Escherichia coli K-12 strain CSH50 was used as host
and transformed with two plasmids with and without hok/
sok genes (pPR95 and pOU82, respectively) (Table 1). Anti
Sok and control PNAs were synthesized and high-
performance liquid chromatography purified by Oswel
Ltd (UK) (21) (Table 1). All PNAs were synthesized
with an attached peptide (KFFKFFKFFK) to enhance cell
uptake (22).
Bacterial growth and minimal inhibitory concentration
(MIC) measurement
Bacteria were grown in Mueller Hinton (MH) broth
containing ampicillin (30 mg/ml) under aeration to mid-log
phase of growth. Inoculums from mid-log phase cultures
were used to initiate cultures at 105 c.f.u./ml in the wells of
ultra low attachment 96-well microplate (Costar 3474, Corn-
ing incorporated, NY) and incubated with PNA at 37C for
20 h. The lowest PNA concentrations that prevented measur-
able cell growth after 20 h were scored as the MIC. C.f.u.
were determined by serial dilutions of cell culture with PBS
followed by plating on LB plates.
Microscopy
Cells morphology was analysed by phase-contrast microscopy
(Zeiss) at 1000· total magnification. Prior to microscopy,
cultures were treated with 8 mM PNA or 150 mg/ml
rifampicin for 3 h and then collected by centrifugation. Digi-
tal images were captured using a CCD camera and Openlab
imaging software, version 3.1.5. (Improvision Ltd).
Northern analysis of mRNA maturation
Total RNA was extracted from mid-log growth phase cultures
using the acid-phenol method as described (23). RNA was
fractionated in a 6% polyacrylamide/urea/TBE gel and
electrotransferred onto a GeneScreen Plus nylon membrane
(Perkin Elmer, USA). Transcripts containing hok sequences
Figure 1. Schematic model of the hok/sok TA system and the Sok-RNA
inhibition strategy used in this study. (A) Full-length hok mRNA folds into a
compact form in which the 50 and 30 ends of the molecule pair. The ends of
the molecule make an exact match, thus generating a highly folded and
‘blunt-ended’ RNA structure. The sequestering of the mRNA 30 end reduces
the rate of 30-processing by polynucleotide phosphorylase and ribonuclease
II (15). However, the 30 exoenzymes removes the terminal 39 nt at the 30 end
of hok mRNA at a low rate. The arrow-head points to the bottom of the stem–
loop structure, which acts as a ‘road-block’ for the 30 end trimming. (B) Via
its 50 end single-stranded tail, Sok-RNA (shown in red) recognises a single-
stranded stem–loop present only in the truncated, refolded hok mRNA. This
is because the 30 trimming of full-length hok mRNA releases the very 50 end
of the mRNA and this release triggers a major refolding of the mRNA 50 end
that results in the formation of the antisense RNA binding stem–loop
structure (26,27). The refolded isoform of the mRNA is metabolically very
stable and binds Sok-RNA avidly, but can also be bound by ribosomes and
therefore be translated (26). In the presence of excess Sok-RNA rapid binding
of the antisense RNA prevents ribosome binding to hok mRNA and thus
prevents its translation (12,26). Eventually, the hok mRNA::Sok-RNA duplex
is formed and then rapidly cleaved (scavenged) by RNase III (18). Therefore,
the truncated form of hok mRNA does not accumulate in Sok-RNA
containing cells. The RNase III cleavage of the hok mRNA::Sok-RNA duplex
is not required for inhibition of hok mRNA translation (41). (C) Sok-RNA
inhibition strategy. PNAs complementary to the single-stranded 50 end of
Sok-RNA (shown in blue) prevent Sok-RNA binding to hok mRNA and
thereby induce hok translation, synthesis of the lethal Hok protein and cell
killing.
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were probed using an oligonucleotide that is complementary
to the 30-terminal region of the hok open reading frame
(Figure 4A): (50-CTACTTACCGGATTCGTAAGCCATGA-
AAGCCGCCACCTCCCTGTGTCCGTCTCTG-30); labelled
using cross-linking alkaline phosphatase and chemifluorescent
detection systems (Amersham Biosciences).
Complex formation and binding kinetics analyses
in vitro
Sok-RNA and the mature, processed form of hok mRNA
were synthesised in vitro using T7 polymerase (Fermentas)
and PCR fragment templates generated using sok and hok pri-
mers: sok F, (50-AAGAAGATAGCCCCGTAGTAAG-30);
sok R, (50-TGTAATACGACTCACTATAGACTAGACAT-
AGGGATGCCTC-30) T7 promoter region is underlined;
hok F, (50-TGTAATACGACTCACTATAGGGCGCTTGA-
GGCTTTCTGC-30) T7 promoter region is underlined; hok
R, (50-AAGGCGGGCCTGCG-30). To determine binding
kinetics, radioactively labelled Sok-RNA was generated by
incorporation of [a-32P]CTP (800 Ci/mmol; Amersham Bio-
science) during T7 transcription. Small amounts of labelled
RNA (3000 c.p.m.) were used to spike non-radioactive
Sok-RNA. For binding reactions we mixed hok mRNA
(30 nM) with Sok-RNA (2 nM) or PNA (500 nM) with
Sok-RNA (38 nM) in TMN buffer [20 mM Tris–OAc
pH 7.5, 10 mM Mg(OAc)2, 100 mM NaCl]. Bound and
unbound fractions were separated on an 8% polyacrylamide
gel containing 7 M urea at 5 V/cm. The radioactive bands
were analysed by autoradiography and densitometry using
ImageQuant software (Molecular Dynamics). To minimise
complex formation during handling prior to electrophoresis,
aliquots were immediately diluted into two volumes of load-
ing buffer (92% formamide, 17 mM Na2EDTA, 0.025%
xylene cyanol and 0.025% bromophenol blue) and loaded
onto gels with current applied at each time point. The second-
order binding-rate constant (k2) was calculated as described
previously (24).
Annotation of antisense RNA-regulated toxin genes
The fully sequenced genomes of 218 prokaryote organisms
were downloaded from the NCBI Web-site and searched
for Hok and Ldr protein-encoding genes using the TBLASTN
program (25). Hok and Ldr sequences of E.coli K-12 were
used as seed sequences (Supplementary Table S1). The
coordinates for each candidate and the encoded protein
sequences are listed in Supplementary Table S1. The toxin
genes were annotated on the genomes using Vector NTI
(version 7.0).
RESULTS
Design of anti Sok PNAs
The secondary structure of Sok-RNA has been established
experimentally (12,14,26,27). The 64 nt long RNA consists
of a stable stem–loop structure and a single-stranded 50-tail
(Figure 1). Initially, the 11 nucleotide-long 50-tail of Sok-
RNA recognises a single-stranded loop in the truncated,
refolded isoform of hok mRNA (12). Therefore, we decided
to design antisense PNAs complementary to the 50 end single-
stranded tail of Sok-RNA in the anticipation that they could
out-compete Sok-RNA binding to hok mRNA and thus
induce hok mRNA translation. We designed and synthesized
PNAs that have 9 (anti Sok PNA-2), 10 (anti Sok PNA-3) or
11 (anti Sok PNA-1) bases complementary to 50-tail of
Sok-RNA.
Anti Sok PNAs inhibit cell growth and are bactericidal
To test whether competitive inhibition of hok mRNA::Sok-
RNA interaction could trigger Hok synthesis in bacteria,
anti Sok PNAs were added to cultures of E.coli cells carrying
the hok/sok locus. Growth was assessed by monitoring the
growth curve as an indicator for cell survival. All three of
the anti Sok PNAs inhibited the growth of a hok/sok-carrying
strain (CSH50/pPR95). Anti Sok PNA-3 was the most potent
of the three anti Sok PNAs (Figure 2A) and no growth was
detected in the culture with 10 mM PNA after 20 h, indicating
an MIC of 10 mM for PNA-3.
To control for possible non-specific effects of PNAs, such
as reduced plasmid copy number, two negative control
experiments were included. First the hok/sok-deficient strain
(CSH50/pOU82) was grown together with anti Sok PNA
and no changes in cell growth were observed, showing that
hok/sok genes are needed for inhibition of cell growth.
Second, a scrambled PNA was introduced to both strains
for detection of any non-specific effect of PNA chemistry.
As expected, cell growth was not affected by these negative
controls. Also, previous studies using targeted and non-
targeted oligomers indicate that PNAs do not reduce plasmid
copy number (22,28). Therefore, the anti Sok PNAs act in a
sequence-specific manner to sequester Sok-RNA and activate
Hok toxin synthesis.
To assess the extent of cell killing by Hok activity, we
treated cells with anti Sok PNAs and determined the number
of viable cells over time by scoring the number of c.f.u. The
results show that Hok induction using anti Sok PNA almost
completely eliminated c.f.u. (Figure 2B). Therefore, hok
induction by competitive inhibition of Sok-RNA binding
can eliminate the vast majority of viable bacteria within a
large E.coli population. For comparison, rifampicin treatment
was included in the experiment. Rifampicin was significantly
less inhibitory than the anti Sok PNAs, even at much higher
concentrations (100–200 mM) (Figure 2B). We cannot
explain this efficiency; however, the results are similar to
those reported by two other laboratories (28,29), which
show that PNA and morpholino (PMO) antisense oligomers
are more potent than ampicillin in E.coli killing assays,
both in vitro and in vivo. Also, unpublished and published
data (30) indicate that PNA oligomers accumulate in
E.coli and are not removed by transporters which efflux
Table 1. Plasmids and PNAs used in this study
Features References
Plasmids
pOU82 bla+, hok/sok, mini-R1 (42)
pPR95 bla+, hok/sok+, mini-R1 (9)
PNAs
Anti Sok PNA-1 (N)-(KFF)3K-eg1-TATGTCTAGTC This study
Anti Sok PNA-2 (N)-(KFF)3K-eg1-TATGTCTAG This study
Anti Sok PNA-3 (N)-(KFF)3K-eg1-TATGTCTAGT This study
Control SP69 (N)-(KFF)3K-eg1-GTTACATGAT (21)
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conventional antimicrobials. Therefore, we can speculate that
cell accumulation and retention of PNA provides the potent
killing activity observed in the c.f.u. assay, whereas
rifampicin and ampicillin are rapidly removed from cells
after plating.
Anti Sok PNAs induce the characteristic ‘ghost cell’
morphology
To confirm that the cell killing observed was due to Hok
synthesis, we studied cell morphology by phase contrast
microscopy (Figure 3). Dead cells with highly condensed
material in the poles and a transparent centre ‘ghost cells’
were observed in cultures of hok/sok-carrying cells treated
with either anti Sok PNA or rifampicin. Again, for compari-
son, the global transcription inhibitor, rifampicin was
included. Rifampicin treatment of hok/sok-carrying cells
leads to a rapid RNase E-mediated degradation of Sok-
RNA (31). Since hok mRNA is much more stable than
Sok-RNA, the decay of Sok-RNA confers derepression
of hok mRNA translation, and cell killing follows. As
expected, rifampicin treatment induced ghost cell morphol-
ogy (Figure 3). As negative controls, we included hok/sok-
deficient cells and an unrelated PNA. In all cases, the samples
Figure 2. Effects of anti Sok PNAs on the growth of E. coli carrying hok/sok
system. (A) Turbidity in an untreated culture (open circle) and cultures
including anti Sok PNAs added at 8 mM (open triangle) and 10 mM (closed
square). (B) C.f.u. in an untreated culture (closed circle) and cultures
containing anti Sok PNA 5 mM (closed triangle) and 10 mM (closed inverted
triangle) and rifampicin at 100 mM ¼ 122 mg/ml (closed square) and
200 mM ¼ 244 mg/ml (closed diamond).
Figure 3. Effect of anti Sok PNAs on cell morphology of E.coli carrying hok/
sok. PNAs and rifampicin were added to growing cells carrying control or
hok/sok-containing plasmids.
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from the negative controls contained cells with a normal cell
morphology. Therefore, anti Sok PNA can inhibit Sok-
mediated repression of hok mRNA. This result supports the
model for direct Sok-RNA pairing with hok mRNA.
Anti Sok PNAs cause mature hok mRNA accumulation
According to the hok/sok model (20), blockage of Sok-RNA
activity should lead to accumulation of the mature 30 end
truncated hok mRNA. Therefore, if the model is correct
and the anti Sok PNAs selectively sequester Sok-RNA, it
should be possible to detect the truncated, mature isoform
of hok mRNA in PNA-treated cells. Total RNA was prepared
from hok/sok-carrying cells that were untreated or treated
with rifampicin or anti Sok PNA at low micromolar concen-
trations for 4 h. Northern analysis was performed using a
probe that was complementary to a downstream region within
the hok open reading frame (Figure 4A). The probe clearly
detected pre-mRNA transcripts in all samples from hok/sok-
carrying cells (Figure 4B). Importantly, in PNA-treated
cells, the mature 30 end truncated form of hok mRNA was
detected. The identity of the mature form of hok mRNA
was indicated by comparison to rifampicin treated cells,
which contain detectable amounts of mature hok mRNA
following transcription arrest (20). Therefore, anti Sok PNA
treatment sequesters free Sok-RNA and leads to accumula-
tion of mature and active hok mRNA. Sequestered Sok
molecules may be protected from 50 end degradation by
RNase E, but it is unlikely that 30 end degradation by PNPase
and RNase II is inhibited (31).
PNA::Sok-RNA complex formation in vitro and
interaction kinetics
The phenotypic effects of anti Sok PNAs suggest that they are
able to compete with the native interactions between hok
mRNA and antisense Sok-RNA. If this is the case, it should
be possible to determine the binding kinetics in vitro. Previ-
ously, the binding-rate for Sok-RNA and hok mRNA interac-
tions was determined in vitro by monitoring complex
formation at low concentrations using gel shift analysis of
radioactively labelled Sok-RNA (14). To determine the
binding-rate for anti Sok PNAs, we first re-established the
hok mRNA::Sok-RNA interaction assay. Using 32P-labelled
Sok-RNA and an excess of the mature form of hok mRNA
we observed a clear reduction in free Sok-RNA and an
increase in a slower migrating hok mRNA::Sok-RNA
complex over time using PAGE (Figure 5A). By quantifying
the reduction in free Sok-RNA we calculated the second-
order binding-rate constant (k2) to be 1.4 · 105 M1 s1
(37C) (Figure 5B), a value that is similar to that reported
previously (14). In the same way, we determined the binding-
rate of PNA::Sok-RNA complexes. Again, there was a clear
reduction in free Sok-RNA (Figure 5A). The reduction in
Sok-RNA over time was quantified and the binding-rate
constant was  6.9 · 103 M1 s1 (37C) (Figure 5B). There-
fore, PNA::Sok-RNA interactions occur less quickly than hok
mRNA::Sok-RNA interactions in vitro. The PAGE analysis
did not reveal distinct PNA::Sok-RNA complexes, possibly
due to the positively charged peptide attached to PNA
and its effects on complex stability and migration during
electrophoresis. These in vitro results suggest that efficient
Figure 4. Effect of anti Sok PNA treatment on hok mRNA processing. (A)
hok mRNA isoforms. The 441 and 398 nt long RNAs are initial hok mRNAs
that are processed into the mature, truncated isoform of 361 bp hok mRNA
(15,19). In the presence of an excess of active Sok-RNA, the truncated
version of the hok mRNA does not accumulate due to rapid Sok-RNA binding
followed by rapid RNase III processing of the hok mRNA::Sok-RNA duplex.
The long isoforms of hok mRNA bind Sok-RNA much slower and therefore
accumulate even in the presence of Sok-RNA (26). The long versions of hok
mRNA cannot bind to ribosomes and be translated and are not harmful to the
cell. (B) Northern analysis of hok mRNAs following exposure to anti Sok
PNA or rifampicin. The initial transcripts and 30 end truncated, mature and
active isoforms of hok mRNA are indicated.
Figure 5. PNA::Sok-RNA complex formation in vitro and binding kinetics.
(A) 32P-Radiolabeled Sok-RNA incubated with a 15-fold molar excess of
unlabelled anti Sok PNA (500 nM) or hok mRNA (30 nM), fractionated in a
polyacrylamide/urea/TBE gel and analysed by autoradiography and densito-
metry. (B) Plots of the fractions of uncomplexed Sok-RNA as a function of
time of incubation, with the binding-rate constants indicated.
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competition for Sok-RNA in cells requires an excess of PNA
relative to hok mRNA. Such an excess is likely to exist as hok
genes are driven by weak promoters and PNA appears to
accumulate in cells and is not removed by drug efflux
pumps (30).
Enterobacteria contain a large numbers of hok/sok and
ldr toxin loci that are regulated by antisense RNAs
Given the efficient killing of E.coli via activation of hok
described above, we found it interesting to describe in detail
the phylogenetic distribution of antisense RNA-regulated
toxin-encoding genes. E.coli K-12 encodes five hok/sok loci
(32) and four ldr (long direct repeats) loci. ldr loci are analo-
gous (but not homologous) to hok/sok loci and encode a small
toxin gene of 30 codons, a small cis-encoded antisense
RNA that represses translation of the toxin gene. Similar to
hok/sok genes, the toxin-encoding mRNA is stable and the
antisense RNA is unstable (33). We searched 218 fully
sequenced genomes exhaustively for the presence of hok
and ldr genes using an approach described previously (34).
An overview of the results is shown in Table 2. Our analysis
shows that ldr loci are found only in a narrow spectrum of
enteric bacteria, including E.coli and Salmonella and Shigella
flexneri species, whereas hok/sok loci are found in a broader
spectrum of enterobacteria, in one Vibrio species, and in one
of four Salmonella species examined. In contrast, protein-
regulated TA genes (e.g. relBE, mazEF etc.) have a much
broader phylogeny (34). We conclude that ldr and hok/sok
loci are confined to enteric and closely related bacteria.
The genomic localizations of hok/sok and ldr loci on two
E.coli strains and 10 additional enteric pathogen species are
shown in Figure 6 and Supplementary Figure S1. For
comparison, the locations of protein-regulated TA loci were
also included. The ldr loci tend to cluster, often on directly
opposite chromosomal locations (i.e. in the four E.coli spe-
cies and in one S.flexneri species). In contrast, hok/sok and
protein-regulated TA loci were almost randomly scattered
on the chromosomes, except in the case of Photorhabdus
luminiscens, which has three clustered hok/sok loci and a
bewilderingly large number of protein-regulated TA loci
(50), many of which are clustered at the terminus (terC)
region. In E.coli K-12, protein-regulated TA loci function
as stress-response elements that regulate cellular metabolism
in starvation conditions or as genetic stabilization elements
that increase the genetic stability of the chromosome
segments on which they reside (35). The cellular functions
of the chromosome-encoded hok/sok and ldr loci are not
yet known but their presence in large numbers is consistent
with a role as genetic stabilization elements (20).
DISCUSSION
Three conclusions can be drawn from the results of these
experiments. First, the data support the sense/antisense
model for hok mRNA::Sok-RNA interactions. Second,
anti Sok PNAs are bactericidal to E.coli containing a hok/
sok plasmid. Third, the results demonstrate that antisense
agents can be used as competitive inhibitors to study
RNA::RNA interactions in bacteria. Furthermore we extend
the previous knowledge of RNA TA systems distribution in
Enterobacteria.
The hok/sok TA system is a paradigm for sense/antisense
RNA interactions (Figure 1). Here we show that anti Sok
PNAs selectively kill hok/sok-carrying E.coli cells. Also,
anti Sok PNAs induced ‘ghost’ cell morphology and accumu-
lation of the mature, 30 end truncated hok mRNA. All of these
effects are characteristic of Hok toxin-mediated cell killing.
Together, the results support the model of sense/antisense
RNA interaction in the hok/sok TA plasmid stability system
in cells.
The presence of hok and other toxin-encoding genes in
many free-living enteric bacteria (Figure 6, Supplementary
Figure S1 and Table S1) provides possibilities to induce
bacterial suicide. The basic idea is to target the antitoxin
inside cells to release expression or activity of the endoge-
nous toxin. The cell-killing activity of Hok toxin is well
established, and purified Hok toxin is bactericidal when
electroporated into E.coli (36). Therefore, hok induction
should kill E.coli. The challenge is to develop molecules
that can enter E.coli and release hok mRNA for translation.
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Figure 6. Localization of hok/sok (red) and the hok/sok-like ldr loci (green)
on two E.coli chromosomes. Protein-regulated TA loci (blue) were included
for comparison (34). The genes were found using tblastn (Supplementary
Table S1) and annotated with VectorNTI.
Table 2. Numbers of hok/sok, ldr and protein-regulated TA loci in enteric
bacteria1
Organism hok
genes
ldr
genes
protein-regulated
TA loci2
E.coli K-12 5 4 5
E.coli CFT073 5 3 5
E.coli 0157 H7 13 3 8
E.coli 0157 H7 EDL933 13 4 8
S.flexneri 2a 301 10 5 3
S.flexneri 2a 2457T 9 3 2
Salmonella typhi 1 2 6
S.typhi Ty2 0 2 6
Salmonella enterica paratypi 0 2 4
S.typhimurium LT2 0 2 8
Photorhabdus luminescens 3 0 50
E.carotivora atroseptica 1 0 14
Vibrio vulnificus CMCP6 chrII 1 0 1
Total number of genes 61 30 120
1V.vulnificus is closely related to enterobacteria but not classified as such.
2Seven gene-families of protein-regulated TA loci are known: relBE, higBA,
parDE, mazEF, phd/doc, vapBC and ccdAB.
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Surprisingly, the anti Sok PNAs caused a greater than five
orders of magnitude reduction in viable cell counts at low
micromolar concentrations. The high level of cell-killing
observed indicates that the anti Sok PNAs are bactericidal
and that the vast majority of cells retain the plasmid and
capacity to produce Hok toxin during treatment. This
suggests that effective competitive inhibitors of antitoxin
RNAs can be designed and with further improvement may
provide effective new antimicrobials. Recent studies using
peritoneal infections in mice suggest that antisense agents
based on PNA and morpholino chemistry are effective
antimicrobials against E.coli when targeting essential genes
(28,37). In the case of PNA and other types of antisense
oligomers, further progress is needed to improve toxicity, dis-
tribution and other drug properties to provide effective
inhibitors for the clinic. We speculate that antitoxin RNAs
may provide more accessible or sensitive targets relative to
growth essential genes. Also, the emergence of drug
resistance would seem unlikely as the target antitoxin struc-
ture is constrained by a need to maintain recognition with
the toxin encoding mRNA. Plasmid loss would provide an
obvious resistance mechanism; however, the level of cell
killing observed compares well with that of conventional
antimicrobials, and targeting chromosome-encoded hok/sok
or ldr loci would circumvent the problem of resistance by
loss of the TA-carrying plasmid. Also we found that the
binding-rate of PNA::Sok-RNA interaction is rapid, but
slower than that for hok mRNA::Sok-RNA interactions.
This result suggests that an excess of PNA relative to hok
mRNA is needed to out-compete the native interactions in
cells; however, a slow dissociation rate for PNA::Sok-RNA
complexes and PNA accumulation is expected and this may
also aid competition. Therefore, while we have observed
hok activation in cells with the present inhibitor design, it
may be possible to more efficiently trigger Hok-mediated
cell death by using antisense agents with faster binding
kinetics, although we suspect that cell delivery will remain
the major limiting factor in this approach.
Many TA loci are chromosomal in pathogenic E.coli (38).
Previously, it was shown that the hok/sok TA gene stability
element is widespread in E.coli plasmids (39) and that the
E.coli genome encodes five hok/sok homologous loci (32).
Using database searches we extend here these previous
analyses to additional enteric bacteria and the results show
a surprising abundance of homologous and analogous TA
loci in pathogen genomes. Interestingly, while hok/sok loci
in E.coli K-12 are inactive, those in the pathogenic Ochmann
ECOR collection are active. However, it is important to
consider that single copy chromosome-encoded toxin genes
may be more difficult to activate than plasmid copies.
RNA::RNA interactions are inherently difficult to study in
cells. One general problem is that sequence mutagenesis
alters both sequence and higher order folding, which could
affect RNA expression, maturation and RNA half-life. Also,
RNA interactions are transient and often involve RNA
isoforms, as exemplified by the hok/sok system. Therefore,
additional methods to probe RNA interactions in living
cells are needed. Competitive inhibition using antisense
agents has been used to sequester microRNAs in mammalian
cells (40), and the same basic approach should prove helpful
in studies of RNA interactions in bacteria. Here we show that
PNA can be used to competitively inhibit RNA::RNA
interactions in bacteria, and the results suggest that this gen-
eral approach using antisense agents and possibly a similar
approach using expressed RNAs can be applied to study
predicted RNA interactions in bacteria.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
This work was supported by the Centre for mRNP Biogenesis
and Metabolism of the Danish National Research Foundation,
and the Swedish Research Council. Funding to pay the Open
Access publication charges for this article was provided by
the Swedish Research Council.
Conflict of interest statement. None declared.
REFERENCES
1. Szymanski,M., Barciszewska,M.Z., Zywicki,M. and Barciszewski,J.
(2003) Noncoding RNA transcripts. J. Appl. Genet., 44, 1–19.
2. Storz,G., Altuvia,S. and Wassarman,K.M. (2005) An abundance of
RNA regulators. Annu. Rev. Biochem., 74, 199–217.
3. Wagner,E.G., Altuvia,S. and Romby,P. (2002) Antisense RNAs in
bacteria and their genetic elements. Adv. Genet., 46, 361–398.
4. Li,Y.Y., Qin,L., Guo,Z.M., Liu,L., Xu,H., Hao,P., Su,J., Shi,Y.,
He,W.Z. and Li,Y.X. (2006) In silico discovery of human natural
antisense transcripts. BMC Bioinformatics, 7, 18.
5. Kiyosawa,H., Yamanaka,I., Osato,N., Kondo,S. and Hayashizaki,Y.
(2003) Antisense transcripts with FANTOM2 clone set and their
implications for gene regulation. Genome Res., 13, 1324–1334.
6. Osato,N., Yamada,H., Satoh,K., Ooka,H., Yamamoto,M., Suzuki,K.,
Kawai,J., Carninci,P., Ohtomo,Y., Murakami,K. et al. (2003) Antisense
transcripts with rice full-length cDNAs. Genome Biol., 5, R5.
7. Gunasekera,A.M., Patankar,S., Schug,J., Eisen,G., Kissinger,J.,
Roos,D. and Wirth,D.F. (2004) Widespread distribution of antisense
transcripts in the Plasmodium falciparum genome. Mol. Biochem.
Parasitol., 136, 35–42.
8. Katayama,S., Tomaru,Y., Kasukawa,T., Waki,K., Nakanishi,M.,
Nakamura,M., Nishida,H., Yap,C.C., Suzuki,M., Kawai,J. et al. (2005)
Antisense transcription in the mammalian transcriptome. Science, 309,
1564–1566.
9. Gerdes,K., Rasmussen,P.B. and Molin,S. (1986b) Unique type of
plasmid maintenance function: postsegregational killing of
plasmid-free cells. Proc. Natl Acad. Sci. USA, 83, 3116–3120.
10. Gerdes,K., Bech,F.W., Jorgensen,S.T., Lobner-Olesen,A.,
Rasmussen,P.B., Atlung,T., Boe,L., Karlstrom,O., Molin,S. and von
Meyenburg,K. (1986a) Mechanism of postsegregational killing by the
hok gene product of the parB system of plasmid R1 and its homology
with the relF gene product of the E.coli relB operon. EMBO J., 5,
2023–2029.
11. Thisted,T. and Gerdes,K. (1992) Mechanism of post-segregational
killing by the hok/sok system of plasmid R1. Sok antisense RNA
regulates hok gene expression indirectly through the overlapping mok
gene. J. Mol. Biol., 223, 41–54.
12. Franch,T., Petersen,M., Wagner,E.G., Jacobsen,J.P. and Gerdes,K.
(1999a) Antisense RNA regulation in prokaryotes: rapid RNA/RNA
interaction facilitated by a general U-turn loop structure. J. Mol. Biol.,
294, 1115–1125.
13. Gultyaev,A.P., Franch,T. and Gerdes,K. (2000) Coupled nucleotide
covariations reveal dynamic RNA interaction patterns. RNA, 6,
1483–1491.
14. Thisted,T., Sorensen,N.S., Wagner,E.G. and Gerdes,K. (1994b)
Mechanism of post-segregational killing: Sok antisense RNA interacts
with Hok mRNA via its 50 end single-stranded leader and competes
with the 30 end of Hok mRNA for binding to the mok translational
initiation region. EMBO J., 13, 1960–1968.
Nucleic Acids Research, 2006, Vol. 34, No. 20 5921
15. Franch,T. and Gerdes,K. (1996) Programmed cell death in bacteria:
translational repression by mRNA end-pairing. Mol. Microbiol., 21,
1049–1060.
16. Thisted,T., Nielsen,A.K. and Gerdes,K. (1994a) Mechanism of
post-segregational killing: translation of Hok, SrnB and Pnd mRNAs of
plasmids R1, F and R483 is activated by 30 end processing. EMBO J.,
13, 1950–1959.
17. Thisted,T., Sorensen,N.S. and Gerdes,K. (1995) Mechanism of
post-segregational killing: secondary structure analysis of the entire
Hok mRNA from plasmid R1 suggests a fold-back structure that
prevents translation and antisense RNA binding. J. Mol. Biol., 247,
859–873.
18. Gerdes,K., Nielsen,A., Thorsted,P. and Wagner,E.G. (1992)
Mechanism of killer gene activation. Antisense RNA-dependent RNase
III cleavage ensures rapid turn-over of the stable hok, srnB and pndA
effector messenger RNAs. J. Mol. Biol., 226, 637–649.
19. Gerdes,K., Thisted,T. and Martinussen,J. (1990b) Mechanism of
post-segregational killing by the hok/sok system of plasmid R1: sok
antisense RNA regulates formation of a hok mRNA species
correlated with killing of plasmid-free cells. Mol. Microbiol., 4,
1807–1818.
20. Gerdes,K., Gultyaev,A.P., Franch,T., Pedersen,K. and Mikkelsen,N.D.
(1997) Antisense RNA-regulated programmed cell death. Annu. Rev.
Genet., 31, 1–31.
21. Dryselius,R., Aswasti,S.K., Rajarao,G.K., Nielsen,P.E. and Good,L.
(2003) The translation start codon region is sensitive to antisense PNA
inhibition in Escherichia coli. Oligonucleotides, 13, 427–433.
22. Good,L., Awasthi,S.K., Dryselius,R., Larsson,O. and Nielsen,P.E.
(2001) Bactericidal antisense effects of peptide-PNA conjugates. Nat.
Biotechnol., 19, 360–364.
23. Aiba,H., Adhya,S. and de Crombrugghe,B. (1981) Evidence for two
functional gal promoters in intact Escherichia coli cells. J. Biol. Chem.,
256, 11905–11910.
24. Persson,C., Wagner,E.G. and Nordstrom,K. (1988) Control of
replication of plasmid R1: kinetics of in vitro interaction between the
antisense RNA, CopA, and its target, CopT. EMBO J., 7, 3279–3288.
25. Altschul,S.F., Gish,W., Miller,W., Myers,E.W. and Lipman,D.J. (1990)
Basic local alignment search tool. J. Mol. Biol., 215, 403–410.
26. Franch,T., Gultyaev,A.P. and Gerdes,K. (1997) Programmed cell death
by hok/sok of plasmid R1: processing at the hok mRNA 30 end triggers
structural rearrangements that allow translation and antisense RNA
binding. J. Mol. Biol., 273, 38–51.
27. Gultyaev,A.P., Franch,T. and Gerdes,K. (1997) Programmed cell death
by hok/sok of plasmid R1: coupled nucleotide covariations reveal a
phylogenetically conserved folding pathway in the hok family of
mRNAs. J. Mol. Biol., 273, 26–37.
28. Tan,X.X., Actor,J.K. and Chen,Y. (2005) Peptide nucleic acid antisense
oligomer as a therapeutic strategy against bacterial infection: proof of
principle using mouse intraperitoneal infection. Antimicrob. Agents
Chemother., 49, 3203–3207.
29. Tilley,L.D., Hine,O.S., Kellogg,J.A., Hassinger,J.N., Weller,D.D.,
Iversen,P.L. and Geller,B.L. (2006) Gene-specific effects of antisense
phosphorodiamidate morpholino oligomer-peptide conjugates on
Escherichia coli and Salmonella enterica serovar typhimurium in pure
culture and in tissue culture. Antimicrob. Agents Chemother., 50,
2789–2796.
30. Good,L., Sandberg,R., Larsson,O., Nielsen,P.E. and Wahlestedt,C.
(2000) Antisense PNA effects in Escherichia coli are limited by
the outer-membrane LPS layer. Microbiology, 146 (Pt 10),
2665–2670.
31. Mikkelsen,D.N. and Gerdes,K. (1997) Sok antisense RNA from
plasmid R1 is functionally inactivated by RNase E and polyadenylated
by poly(A) polymerase I. Mol. Microbiol., 26, 311–320.
32. Pedersen,K. and Gerdes,K. (1999) Multiple hok genes on the
chromosome of Escherichia coli. Mol. Microbiol., 32, 1090–1102.
33. Kawano,M., Oshima,T., Kasai,H. and Mori,H. (2002) Molecular
characterization of long direct repeat (LDR) sequences expressing a
stable mRNA encoding for a 35-amino-acid cell-killing peptide and a
cis-encoded small antisense RNA in Escherichia coli. Mol. Microbiol.,
45, 333–349.
34. Pandey,D.P. and Gerdes,K. (2005) Toxin–antitoxin loci are highly
abundant in free-living but lost from host-associated prokaryotes.
Nucleic Acids Res., 33, 966–976.
35. Gerdes,K., Christensen,S.K. and Lobner-Olesen,A. (2005) Prokaryotic
toxin–antitoxin stress response loci. Nature Rev. Microbiol., 3,
371–382.
36. Pecota,D.C., Osapay,G., Selsted,M.E. and Wood,T.K. (2003)
Antimicrobial properties of the Escherichia coli R1 plasmid host
killing peptide. J. Biotechnol., 100, 1–12.
37. Geller,B.L., Deere,J., Tilley,L. and Iversen,P.L. (2005) Antisense
phosphorodiamidate morpholino oligomer inhibits viability of
Escherichia coli in pure culture and in mouse peritonitis. J. Antimicrob.
Chemother., 55, 983–988.
38. Schneider,D., Duperchy,E., Depeyrot,J., Coursange,E., Lenski,R. and
Blot,M. (2002) Genomic comparisons among Escherichia coli strains
B, K-12, and O157:H7 using IS elements as molecular markers. BMC
Microbiol., 2, 18.
39. Gerdes,K., Poulsen,L.K., Thisted,T., Nielsen,A.K., Martinussen,J. and
Andreasen,P.H. (1990a) The hok killer gene family in gram-negative
bacteria. New Biol., 2, 946–956.
40. Lee,Y.S., Kim,H.K., Chung,S., Kim,K.S. and Dutta,A. (2005)
Depletion of human micro-RNA miR-125b reveals that it is critical for
the proliferation of differentiated cells but not for the down-regulation
of putative targets during differentiation. J. Biol. Chem., 280,
16635–16641.
41. Franch,T., Thisted,T. and Gerdes,K. (1999b) Ribonuclease III
processing of coaxially stacked RNA helices. J. Biol. Chem., 274,
26572–26578.
42. Gerdes,K., Larsen,J.E. and Molin,S. (1985) Stable inheritance of
plasmid R1 requires two different loci. J. Bacteriol., 161, 292–298.
5922 Nucleic Acids Research, 2006, Vol. 34, No. 20
